| Literature DB >> 10516573 |
Abstract
Over the last ten years, nmr spectroscopy has evolved into an important discipline in drug discovery. Initially, nmr was most useful as a technique to provide structural information regarding protein drug targets and target-ligand interactions. More recently, it has been shown that nmr may be used as an alternative method for identification of small molecule ligands that bind to protein drug targets. High throughput implementation of these experiments to screen small molecule libraries may lead to identification of potent and novel lead compounds. In this review, we will use examples from our own research to illustrate how nmr experiments to characterize ligand binding may be used to both screen for novel compounds during the process of lead generation, as well as provide structural information useful for lead optimization during the latter stages of a discovery program. Copyright 1999 John Wiley & Sons, Inc.Mesh:
Substances:
Year: 1999 PMID: 10516573 DOI: 10.1002/(SICI)1097-0282(1999)51:3<221::AID-BIP5>3.0.CO;2-9
Source DB: PubMed Journal: Biopolymers ISSN: 0006-3525 Impact factor: 2.505